Price target
40.250.000.00%
The 4 analysts offering 1 year price forecasts for RNAC have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to RNAC in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RNAC EPS for the last quarter is −1.13 USD despite the estimation of −0.80 USD. In the next quarter EPS is expected to reach −0.79 USD. Track more of Cartesian Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cartesian Therapeutics, Inc. revenue is expected to reach 160.00 K USD. Check out Cartesian Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RNAC price target is 40.25 USD with a max estimate of 41.00 USD and a min estimate of 39.00 USD. Check if this forecast comes true in a year, meanwhile watch Cartesian Therapeutics, Inc. stock price chart and keep track of the current situation with RNAC news and stock market news.
We've gathered opinions of 6 analysts rating RNAC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.